Shares of Sagility India fell nearly 4% on October 23, a day after the healthcare technology services provider reported robust results for the September quarter, with revenue and EBITDA growing over 22% year-on-year.
Sagility stocks were trading at Rs 43.59 on the NSE, down 3.97%, at 1:32 pm.
The company reported a 22.5% year-on-year increase in Q2FY27 revenue to Rs 2,032.1 crore, while EBITDA rose 23.4% to Rs 512.3 crore. Its adjusted EBITDA margin expanded to 26.3%, prompting the company to raise its FY27 adjusted EBITDA margin guidance to 25-26% from 24-25% earlier. Net profit increased 13.1% year-on-year to Rs 284 crore.
Nomura has retained its 'Neutral' rating on Sagility India while raising its target price to Rs 56 from Rs 53 after factoring in the header should have buy sell or hldQ2FY27 results.
The brokerage said revenue of $213 million, up 11.9% year-on-year in constant currency terms, was in line with its estimates. However, the EBITDA margin of 26.1% beat its estimate of 24%, rising 230 basis points quarter-on-quarter and 110 basis points year-on-year. Diluted earnings per share increased 15% year-on-year to Rs 0.61.